Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

For consumers, generative AI is about creativity, speed, and accessibility. But, while Consumer GenAI races ahead, Enterprise GenAI – especially in regulated fields like pharma – is a ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

In recent years, artificial intelligence (AI) has infiltrated every industry, streamlining processes, optimizing insights and ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property ...

While marketers know that an omnichannel approach can deliver a more seamless brand experience, many pharma companies are still in the early stages of implementing fully integrated omnichannel ...

The PREPARE Challenge, sponsored by the NIA, encourages novel approaches for early AD detection using AI-driven tools that improve accuracy, affordability, and accessibility for patients. As a ...